Shinobu Tomochika
-
- Pancreatic and Hepatic Oncology Research 8
- Colorectal Cancer Surgical Treatments 5
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 4
-
- Esophageal Cancer Research and Treatment 5
- Esophageal and GI Pathology 4
- Anorectal Disease Treatments and Outcomes 3
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
- Co-authors
- Shigeru TakedaNobuaki SuzukiShigefumi YoshinoMichihisa IidaShoichi HazamaTomio UenoYukio TokumitsuShinsuke Kanekiyo
- Cited by
- Cancer ResearchOncologySurgery
- Partner nations
- Japan
In The Last Decade
Shinobu Tomochika
28 papers receiving 279 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 72
- Oncology 125
- Surgery 108
- Immunology 51
- Pulmonary and Respiratory Medicine 70
Countries citing papers authored by Shinobu Tomochika
This map shows the geographic impact of Shinobu Tomochika's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinobu Tomochika with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinobu Tomochika more than expected).
Fields of papers citing papers by Shinobu Tomochika
This network shows the impact of papers produced by Shinobu Tomochika. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinobu Tomochika. The network helps show where Shinobu Tomochika may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shinobu Tomochika, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | [A Case in Which FOLFOXIRI Was Useful as Preoperative Chemotherapy for Locally Advanced Rectal Cancer with Difficulty in Securing CRM]. | 2022 | 0 |
| 9 | [A Case of Intrahepatic Cholangiocarcinoma in the Elderly Patient with Curative Resection after Neoadjuvant Chemotherapy]. | 2021 | 3 |
| 10 | 2020 | 29 | |
| 11 | 2020 | 8 | |
| 12 | [A Case of Primary Liposarcoma of Pancreas Difficult to Diagnose Preoperatively]. | 2020 | 0 |
| 13 | [A Case of Borderline Resectable Pancreatic Adenosquamous Carcinoma Achieving Pathological Complete Response]. | 2019 | 1 |
| 14 | 2018 | 54 | |
| 15 | 2017 | 32 | |
| 16 | [A Case of Conversion Surgery for Unresectable Colorectal Liver Metastases, Following Effective Combined Chemotherapy with Molecular Targeting Agents]. | 2017 | 1 |
| 17 | 2016 | 23 | |
| 18 | 2009 | 18 | |
| 19 | 2004 | 0 | |
| 20 | 2003 | 2 |
About Shinobu Tomochika
Shinobu Tomochika is a scholar working on Oncology, Hepatology and Surgery, having authored 39 papers that have together received 285 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Colorectal Cancer Surgical Treatments (5 papers), Esophageal Cancer Research and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Esophageal and GI Pathology (4 papers), Anorectal Disease Treatments and Outcomes (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Cancer Research (72 citations), Oncology (125 citations) and Surgery (108 citations). Shinobu Tomochika has collaborated with scholars based in Japan. Frequent co-authors include Shigeru Takeda, Nobuaki Suzuki, Shigefumi Yoshino, Michihisa Iida, Shoichi Hazama, Tomio Ueno, Yukio Tokumitsu, Shinsuke Kanekiyo, Kazuhiko Sakamoto and Yoshihiro Tokuhisa. Their work appears in journals such as Cancer Science, Anticancer Research, Nutrition, Oncology Reports and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.